Companies such as Novo Nordisk and Eli Lilly have sent cease-and-desist letters to parties involved in the manufacture, sale, and distribution of unauthorized GLP-1 products
Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, et al
AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance
Conagra Brands Conagra Brands has introduced a labeling system for Healthy Choice frozen meals that caters to individuals using GLP-1 drugs
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society